GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Despite a 37% stock decline since August, Illumina remains a leader in NGS with promising long-term growth, though the short-term outlook is cautious. Illumina's Q4 financials show improved gross ...

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

The import ban on Illumina’s NGS sequencers follows its placement on China’s Ministry of Commerce’s (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock. China has ...

which is expected to directly compete with Illumina’s next-generation sequencing (NGS) portfolio. Roche’s management has expressed confidence that SBX can produce data comparable to NGS, while also ...

which is expected to directly compete with Illumina’s next-generation sequencing (NGS) portfolio. Roche’s management has expressed confidence that SBX can produce data comparable to NGS ...

Victor Davis Hanson, a senior contributor for The Daily Signal, is a classicist and historian at the Hoover Institution at Stanford University and author of the book "The Second World Wars ...

eye.ox.ac.uk Genetics has been revolutionised by recent technologies. The latest addition to these advances is next-generation sequencing, which is set to transform clinical diagnostics in every ...

uhn.ca The purpose of this document is to provide guidance for the use of next-generation sequencing (NGS, also known as massively parallel sequencing or MPS) in Canadian clinical genetic laboratories ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

This is why we partnered with Illumina, the leading NGS provider, integrating our DNA ... grew double digits year-over-year, a strong signal of a broadening adoption. As we roll out additional ...